Background-Sodium channels isolated from mammalian brain are composed of ␣-, ␤ 1 -, and ␤ 2 -subunits. The composition of sodium channels in cardiac muscle, however, has not been defined, and disagreement exists over which ␤-subunits are expressed in the myocytes. Some investigators have demonstrated ␤ 1 expression in heart. Others have not detected any auxiliary subunits. On the basis of Northern blot analysis of total RNA, ␤ 2 expression has been thought to be exclusive to neurons and absent from cardiac muscle. Methods and Results-The goal of this study was to define the subunit composition of cardiac sodium channels in myocytes. We show that cardiac sodium channels are composed of ␣-, ␤ 1 -, and ␤ 2 -subunits. Nav1.5 and Nav1.1 are expressed in myocytes and are associated with ␤ 1 -and ␤ 2 -subunits. Immunocytochemical localization of Nav1.1, ␤ 1 , and ␤ 2 in adult heart sections showed that these subunits are expressed at the Z lines, as shown previously for Nav1.5. Coexpression of Nav1.5 with ␤ 2 in transfected cells resulted in no detectable changes in sodium current. Conclusions-Cardiac sodium channels are composed of ␣-(Nav1.1 or Nav1.5), ␤ 1 -, and ␤ 2 -subunits. Although ␤ 1 -subunits modulate cardiac sodium channel current, ␤ 2 -subunit function in heart may be limited to cell adhesion.
V oltage-gated sodium channels initiate action potentials in excitable cells. 1 Brain sodium channels are composed of a single pore-forming ␣-subunit and 2 auxiliary ␤-subunits, with a stoichiometry of 1:1:1. 1 ␤-Subunits do not form the ion-conducting pore but rather modulate channel gating and cell surface expression levels and interact with extracellular matrix and cell adhesion molecules. 2 Recently, 2 additional members of the ␤-subunit gene family have been identified: ␤ 1 A and ␤ 3 . 3, 4 The subunit structure of cardiac sodium channels has not been well defined. At least 2 ␣-subunit mRNAs are expressed in heart: Nav1.5 and Nav1.1. 5 ␤ 1 -Subunit mRNA is expressed in rat and human heart 6, 7 but was not detected in mouse heart. 8 ␤ 1 -Subunit polypeptides have been demonstrated in rat heart 9 ; however, purified preparations of cardiac sodium channels from chicken and rat did not show detectable associated ␤-subunits after immunoprecipitation with ␣-subunit antibodies. 10, 11 Nav1.5ϩ␤ 1 coexpression has been studied in heterologous expression systems with variable and conflicting results. 7,12-16 ␤ 1 A polypeptides and ␤ 3 mRNA have also been detected in heart. 3, 4 ␤ 2 transcripts are not detectable in heart by Northern blotting techniques. 17 Thus, it was postulated that ␤ 1 , ␤ 1 A, and ␤ 3 may be expressed in heart, whereas ␤ 2 was most likely absent. Recent studies, however, have compelled us to reexamine this hypothesis. Nav1.5 sodium channels become permeable to Ca 2ϩ after activation of protein kinase A. 18 This mode of the channel, called slip-mode conductance, requires ␤ 1 and ␤ 2 coexpression with ␣. Nav1.5 ␣and ␤ 2 -subunits covalently associate in HEK293 cells 18 ; it was not determined, however, whether ␤ 2 -subunits are expressed in cardiac muscle.
The purpose of this study was to define the sodium channel ␣and ␤-subunits expressed in cardiac myocytes. Using specific antibodies, we identified Nav1.1, Nav1.5, ␤ 1 , and ␤ 2 . The developmental time course of ␤ 2 expression in heart shows that it is detectable by postnatal day 15. Nav1.5, ␤ 1 , and ␤ 2 associate in cardiac myocytes, as do Nav1.1, ␤ 1 , and ␤ 2 . Immunocytochemistry revealed Nav1.1, ␤ 1 , and ␤ 2 expression in adult cardiac muscle along the Z lines. Coexpression of Nav1.5 and ␤ 2 -subunits in tsA201 cells did not result in any detectable changes in sodium current over ␣ alone. We conclude that cardiac sodium channels contain ␤ 1 -and ␤ 2 -subunits and that either Nav1.1 or Nav1.5 ␣-subunits can form the ion-conducting pore.
Methods

Antibodies
Antibodies to ␤ 1 or ␤ 2 used for Western blots were described previously. 19, 20 An extracellular epitope ␤ 2 antibody was obtained from Dr W.A. Catterall, University of Washington, and used for immunolocalization. Anti-SP11-I 21 and anti-rH1 were obtained from Alomone Laboratories. The anti-rH1 antibody was raised in rabbit against the peptide D 492 RLPKSDSEDGPRALNQLS 510 (C) with an additional C-terminal cysteine and affinity-purified. Anti-cardiac ␣-sarcomeric actin and anti-␣-actinin were from Sigma. Fluorescent secondary antibody conjugates were from Vector Laboratories.
Human Fetal Heart ␤ 2 cDNA Clone
A cDNA clone for a human fetal heart sodium channel ␤ 2 -subunit was obtained as previously described (accession number AF107028). 18
RT-PCR Analysis of Rat and Mouse mRNA
Poly-A mRNA was obtained from Clonetech. Reverse transcriptionpolymerase chain reaction (RT-PCR) was performed by use of the Titan One Tube PCR system (Roche Molecular Biochemicals). Primers CTFNS (5Ј-CTGTACCTTCAACTCCTGCTATACC-3Ј) and E3Ј (5Ј-ATGACTGCCACCGTGGAGTCCCGCTCTG-3Ј) were used. Each reaction contained 50 ng of mRNA. First-strand cDNA was synthesized at 55°C for 30 minutes, and then PCR was performed as follows: 94°C for 2 minutes; 10 cycles of 94°C for 15 seconds, 65°C for 30 seconds, and 68°C for 30 seconds; and 25 cycles of 94°C for 15 seconds, 65°C for 30 seconds, and 68°C for 30 seconds, plus 5 additional seconds for each cycle. A final step for 7 minutes at 68°C was performed. This PCR amplifies a 335-bp product from mRNA and a 1061-bp product from genomic DNA that includes introns 1 and 2 of SCN2B.
Northern Blot Analysis of Total Mouse RNA
Samples of total mouse mRNA were purified with Trizol reagent (Life Technologies). Northern blot analysis was performed as previously described. 17
Preparation and Culture of Cardiac Myocytes
Primary cultures of neonatal rat cardiac myocytes were prepared as previously described. 22 Myocytic purity was monitored by immunofluorescence using anti-cardiac ␣-sarcomeric actin and averaged 96Ϯ3% 48 hours after plating.
Expression of Nav1.5 Sodium Channels in HEK Cells
Nav1.5 cDNA was subcloned into pcDNA3.1/Zeo (ϩ) (Invitrogen), and HEK 293 cells were transfected with lipofectamine (Life Technologies). Clones were selected with 400 g/mL zeocin (Invitrogen) and tested electrophysiologically for the presence of sodium current. Clone 21, used in this study, showed current amplitude of Ϸ500 pA/pF and was maintained in culture with 200 g/mL zeocin.
Immunoprecipitation and Western Blot
Immunoprecipitations were performed from heart membranes, prepared as described for brain, 23 or solubilized cardiac myocytes. Western blot analysis of cardiac ␣-subunits was performed as described. 20 Immunocytochemical Analysis of Nav1.1 ␣, ␤ 1 , and ␤ 2 Expression in Heart Mice were anesthetized by intraperitoneal injection of Beuthanasia-D (Schering-Plough Animal Health Corp). Hearts were washed by injection of 50 mL prewashing buffer (g/L: NaCl 8, dextrose 4, sucrose 8, calcium chloride 0.23, sodium cacodylate 0.34) and perfused with 50 mL perfusion solution (g/L: sucrose 40, Figure 1 . Antibody specificity. A, Nav1.1 and Nav1.5 expression in brain and cardiac myocytes. Total lysates of cardiac myocytes (100 g) or rat brain membranes (100 g) were boiled in SDS-PAGE sample buffer containing 5% ␤-mercaptoethanol, separated on 5% acrylamide SDS-PAGE gels, and transferred to nitrocellulose. Western blots were probed with anti-SP11-I antibody or anti-rH1 antibody, each at 1:500 dilution, followed by secondary antibody at 1:100 000 dilution. B, Specificity of antibodies for Nav1.5. Total lysates of HEK 293 cells (50 g) stably transfected with Nav1.5 were boiled in SDS-PAGE sample buffer containing 5% ␤-mercaptoethanol, separated on 5% acrylamide SDS-PAGE gels, and transferred to nitrocellulose. Western blots were probed with anti-SP11-I (1:250) or anti-rH1 (1:200) antibody followed by secondary antibody as above. Molecular weight markers in A and B are expressed in kDa. paraformaldehyde 40, sodium cacodylate 14.34). Hearts were incubated in perfusion solution at 4°C overnight with constant rotation. The solution was changed to 30% sucrose, and the incubation was continued overnight at 4°C with constant rotation. Cryostat sections (0.4 m thick) were cut and postfixed in 2% paraformaldehyde, treated for 10 minutes with 0.5% Triton X-100 in TBS buffer (10 mmol/L Tris-HCl [pH 7.5], 150 mmol/L NaCl), and then blocked at room temperature in the same solution containing 5% newborn calf serum. Primary antibodies (anti-SP11-I, 1:100; anti-␤ 1 , 1:100; anti-␤ 2 , extracellular epitope 1:50; anti-␣ actinin, 1:400) or primary antibodies preadsorbed with peptides (40 g/mL for ␤ 1 or ␤ 2 , 50 g/mL for Nav1.1) were then added to the above solution, which also contained 0.1% Tween-20, and incubated for 1.5 hours at room temperature. The sections were washed with TBS-T. Secondary antibodies (fluorescein isothiocyanate-conjugated goat anti-rabbit IgG for ␣, ␤ 1 , and ␤ 2 or Texas red-conjugated goat anti-mouse IgG for ␣-actinin) were then added, and the incubation was continued for 1.5 hours at room temperature. Sections were washed, mounted with Dabco (Sigma), and visualized with a BioRad MRC 600 confocal laser scanning microscope in the Microscopy and Image Analysis Laboratory Core Facility at the University of Michigan.
Electrophysiology
Cell Culture
TsA201 cells (a gift from Dr Mohamed Chahine, University of Laval) were grown under standard conditions and transfected with Nav1.5 alone or Nav1.5ϩh␤ 1 -, Nav1.5ϩh␤ 2 -, or Nav1.5ϩh␤ 1 ϩh␤ 2subunits with lipofectamine as described. 24 
mRNA Extraction and RT-PCR
mRNA extraction and RT-PCR were performed with the mRNA Captur(e) Kit and the Titan One Tube RT-PCR kit (Roche Molecular Biochemicals). The primers used were, for the detection of h␤ 1 : SCN1B-F(5Ј-GACCAACGCTGAGACCTTCAC-3Ј)/SCN1B-R(5Ј-CACGAGCCATATGGTCAACAC-3Ј); for the detection of h␤ 2 : h␤ 2 n90 (5Ј-GGAGGTCACAGTACCTGCCACCCTC-3Ј)/h␤ 2 n480 (5Ј-CACGGCCACCGTGAAGTCCC-3Ј); and for the detection of human ␤-actin: h␤-ACTIN556F (5Ј-CACTGTGCCCATCTAC-GAGG-3Ј)/h␤-ACTIN1169R(5Ј-CGGACTCGTCATACTCC-TGCTT-3Ј). First-strand cDNA was synthesized at 60°C for 30 minutes, and then PCR was performed as follows: 94°C for 2 minutes, then 10 cycles of 94°C for 30 seconds, 55°C (for h␤ 1 and h␤ 2 ) or 45°C (for h␤-actin) for 30 seconds, and 68°C for 45 seconds, followed by 25 cycles of 94°C for 30 seconds, 55°C or 45°C as described above for 30 seconds, and 68°C for 45 seconds, plus 10 additional seconds for each cycle. A final step for 7 minutes at 68°C was then performed. Membranes were prepared and solubilized as described in Methods. Soluble fraction was immunoprecipitated with anti-rH1 antibody (1:500 dilution) as described. Western blots were probed with antibodies to ␤ 1 (left) or ␤ 2 (right) (1:500 dilution for each) and then with secondary antibody (1:100 000 dilution). NI indicates nonimmune serum; ␣, anti-rH1 antibody; ␤ 1 , anti-␤ 1 antibody; and ␤ 2 , anti-␤ 2 antibody. 
Whole-Cell Voltage Clamp
Currents were measured at room temperature by whole-cell patchclamp procedures with Axopatch 200B amplifiers (Axon Instruments) with previously described recording solutions and voltage protocols. 24 Data were collected and analyzed with pClamp8 and Origin software (Axon Instruments and Microcal Software). The voltage-dependence of inactivation was determined by measuring current in response to pulses to Ϫ20 mV that had been preceded by conditioning pulses (500 ms) to a series of voltages. Holding potentials were Ϫ100 mV, and [Na ϩ ] o was 130 mmol/L. For the voltage-dependence of activation, current was measured in response to pulses from Ϫ80 to ϩ60 mV, and [Na ϩ ] o was 10 mmol/L (with N-methyl-glucamine used as an equimolar Na ϩ substitute). Data are presented as meanϮSEM. Two-tailed Student's t test was used to compare means; a value of PϽ0.05 was considered statistically significant. Data were filtered with a Boltzmann relationship, where V 1/2 is the voltage where half of the channels are available (or activated) and k is the slope factor.
Results
Antibody Specificity
To determine the specificity of the rH1 antibody for Nav1.5, we performed Western blots of heart and brain membranes using anti-rH1 versus anti-SP11-I antibodies. Using anti-SP11-I, we observed that Nav1.1 is expressed both in brain and in cardiac myocytes, whereas Nav1.5 could be detected Figure 6 . Immunolocalization of ␤ 1 and ␤ 2 in heart. Longitudinal heart sections were processed for double immunofluorescence with anti-␤ 1 (A) and anti-␣-actinin (B) antibodies or anti-␤ 2 (D) and anti-␣-actinin (E) antibodies. C and F were labeled with ␤ 1 or ␤ 2 antibodies, respectively, that had been preadsorbed with peptide (40 g/mL). Scale barϭ100 m.
in myocytes but not in brain membranes with anti-rH1 ( Figure 1A) . Figure 1B shows that anti-rH1, but not anti-SP11-I, recognizes Nav1.5 sodium channels expressed in HEK 293 cells. These results indicated that the 2 antibodies are selective for the 2 channel subtypes and that crossreactivity would not complicate our experiments.
Expression of ␤ 2 mRNA in Heart
Our previous studies suggested that ␤ 2 expression is limited to neuronal tissues. 17 Thus, we decided to retest cardiac RNA for ␤ 2 expression by more sensitive methods. RT-PCR showed that ␤ 2 mRNA is expressed in mouse heart (Figure 2A ). This experiment was designed with Figure 2B ) such that contaminating genomic DNA could be clearly separated from the lower-molecularweight mRNA (cDNA) band (Figure 2A, arrows) . Northern blot experiments confirmed our previous results that ␤ 2 transcript is not detectable in total heart RNA (data not shown). We conclude that ␤ 2 mRNA is present in cardiac muscle tissue, but at significantly lower levels than in brain.
␤ 1 and ␤ 2 Associate With Cardiac Sodium Channels
Analysis of heart membranes in the presence and absence of ␤-mercaptoethanol showed the presence of an immunoreactive ␤ 2 band that shifted on reduction from Ͼ200 kDa to 33 kDa, indicating ␣-␤ 2 covalent interactions ( Figure 3A) . Western blot analysis of primary cardiac myocytes with anti-␤ 2 antibody revealed an immunoreactive band at Ϸ40 kDa ( Figure 3B ). Figure 3C shows the developmental time course of ␤ 2 expression in heart from early embryo to adulthood. ␤ 2 -Subunits are expressed only after birth, becoming detectable at postnatal day 15. Coimmunoprecipitation experiments showed that in heart membranes (Figure 4 ) as well as in myocytes ( Figure 5A ), Nav1.5 associates with ␤ 1 and ␤ 2 . Figure 5B demonstrates that ␤ 1 and ␤ 2 are also associated with Nav1.1 in cardiac myocytes. Thus, sodium channels in cardiac myocytes are composed of ␣-, ␤ 1 -, and ␤ 2 -subunits, and either Nav1.1 or Nav1.5 can form the ion-conducting pore.
Immunolocalization of Nav1.1 ␣, ␤ 1 , and ␤ 2 in Heart
Previous immunolocalization of Nav1.5 revealed labeling of surface and T-tubular membrane systems of atrial and ventricular myocytes when viewed in cross section. In longitudinal sections, labeling was also observed at terminal intercalated disks in ventricular muscle in accordance with Z-line appearance. 25 We used Nav1.1, ␤ 1 , and ␤ 2 antibodies to investigate the localization of these subunits in longitudinal sections of cardiac muscle. As shown in Figure 6 , A and D, both ␤ 1 and ␤ 2 colocalized with ␣-actinin ( Figure 6, B and E) , a marker for cardiac-muscle Z lines. As shown in Figure 7 , A and B, Nav1.1 also showed a labeling pattern similar to that of ␣-actinin. Because anti-SP11-I antibody does not recognize Nav1.5 ( Figure 1B) , we could be confident that our results were not complicated by antibody cross-reactivity and that Nav1.1 is indeed expressed in the myocytes. Antibodies preadsorbed with peptides showed no specific signals ( Figure  6 , C and F; Figure 7C ). The Nav1.1 ␣-, ␤ 1 -, and ␤ 2 -labeling results are similar to previous results for Nav1.5. 25 Thus, Nav 1.1, Nav1.5, and ␤-subunits are colocalized in heart muscle.
Electrophysiological Analysis
We used RT-PCR to investigate the presence of endogenous sodium channel auxiliary subunits in tsA201 cells. Figure 8 indicates that endogenous expression of ␤ 2 is not detected in our assays. In contrast, tsA201 cells do express ␤ 1 mRNA. Transfection with ␤ 1 strongly increased the level of ␤ 1 mRNA, however, suggesting that it might be possible to detect functional consequences of coexpression of Nav1.5 with both ␤-subunits in this cell line. We expressed Nav1.5 with and without h␤ 1 and h␤ 2 in tsA201 cells and studied the properties of the expressed channels (Table) . We found no differences in peak current density due to h␤ 1 or h␤ 2 , but did detect an effect of h␤ 1 on the voltage-dependence of inactivation. Coexpression of Nav1.5 with h␤ 1 caused a significant ϩ5-mV shift in the half-maximal voltage-dependence of inactivation (V 1/2 ), similar to previous reports. 16 These data indicate that the endogenous levels of ␤ 1 expression in tsA201 cells are not sufficient to saturate the effect of ␤ 1 on 
Influence of ␣and ␤-Subunit Coexpression on the Voltage-Dependence of Sodium Channel Inactivation
SCN5Aϩh␤2
Ϫ308Ϯ42 (7) Ϫ77.1Ϯ1.1 5.1Ϯ0.1 (7) Ϫ23.2Ϯ1 5.9Ϯ0.2 (5)
SCN5Aϩh␤1ϩh␤2
Ϫ441Ϯ63 (7) Ϫ74.0Ϯ1.0* 4.9Ϯ0.2 (7) Ϫ24.3Ϯ2 5.8Ϯ0.2 (5) Steady-state inactivation and activation curves were determined as described in Methods for a series of cells transfected with various subunit combinations. Inactivation and activation curves were fitted by Boltzmann functions. V 1 ⁄2 is the voltage for which half the channels are inactivated or activated; k is the slope factor of the Boltzmann curve. Numbers of cells are in parentheses.
inactivation. Because of the endogenous ␤ 1 , the 5-mV shift we measure is likely to be an underestimate of the influence of ␤ 1 on inactivation. In contrast to ␤ 1 , we did not detect any functional effects of coexpression of Nav1.5 with ␤ 2 on the voltage-dependence of inactivation or activation.
Discussion
Sodium channels isolated from mammalian brain are composed of 1 ␣and 2 ␤-subunits. 1 The subunit structure of cardiac sodium channels has not been as well defined. At least 2 ␣-subunit mRNA transcripts, Nav1.1 and Nav1.5, have been identified in adult heart. 5, 26 High-and low-affinity populations of STX receptors, presumably corresponding to Nav1.1 and Nav1.5, respectively, have also been identified in adult rat heart, with high-affinity receptors estimated to make up 25% to 50% of the total population of sodium channels. 5 ␤ 1 mRNA and protein are expressed in heart tissue at high levels 6, 9 ; however, its association with ␣-subunits has not been demonstrated. ␤ 2 transcripts are not detectable in total cardiac RNA by Northern blotting techniques. 17 In purified preparations of chicken and rat cardiac sodium channels, ␤-subunits could not be detected at all. 10, 11 Thus, although a number of investigators presumed that cardiac sodium channels were most likely composed of ␣and ␤ 1 -subunits, this has remained controversial. The purpose of the present study was to define the subunit composition of cardiac sodium channels. Cardiac myocytes express ␤ 1 and ␤ 2 polypeptides, and Nav1.5 physically associates with both ␤-subunits. ␤ 2 -Subunit polypeptides are expressed postnatally in heart. ␣-, ␤ 1 -, and ␤ 2 -subunits are localized to the Z lines in heart sections. We also identified Nav1.1 in cardiac myocytes and showed that it associates with ␤ 1 and ␤ 2 . We conclude that sodium channels expressed in cardiac myocytes are composed of either Nav1.1 or Nav1.5 and that both associate with ␤ 1 and ␤ 2 . Although ␤ 1 has modulatory effects on Nav1.5, ␤ 2 has no detectable effects in our system, suggesting that the effects of ␤ 2 in heart in vivo may involve cell adhesion and cytoskeletal communication as opposed to channel gating.
What is the physiological role of ␤-subunits in heart? Brain and skeletal muscle sodium channels expressed in oocytes exhibit slow inactivation kinetics. Coexpression of ␤ 1subunits produces a significant increase in the rate of inactivation of these channels. 27, 28 In contrast, expression of Nav1.5 in oocytes produces channels that inactivate rapidly in the absence of ␤-subunits. 13 Some groups have reported that ␤ 1 has no observable effects on Nav1.5 functional expression. 7, 12 Others reported that coexpression of ␤ 1 and Nav1.5 results in increased current density with no detectable effects on channel kinetics or voltage-dependence. 13, 14 Some groups have found modulation of channel sensitivity to lidocaine block and subtle changes in channel kinetics and gating properties in response to ␤ 1 expression, 15 whereas others have reported significant shifts in the voltage-dependence of steady-state inactivation, similar to the present results. 16 A Nav1.5 mutation associated with long-QT syndrome affects the voltage-dependence of channel inactivation by altering the interaction of Nav1.5 and ␤ 1 . 16 Finally, Nav1.1 ␣-subunits are modulated by ␤ 1 -and ␤ 2 -subunits when expressed in oocytes. 28 Thus, ␤-subunits may modulate cardiac sodium channels and play a role in cardiac physiology. ␤ 1 and ␤ 2 are cell adhesion molecules of the immunoglobulin superfamily. 27 Both interact with extracellular matrix molecules and participate in homophilic cell adhesion, resulting in cellular aggregation and recruitment of ankyrin to the plasma membrane at points of cell-cell contact. 2 We have proposed that a major function of ␤-subunits is cell adhesion, contributing to channel localization, clustering, and nodal formation in brain and peripheral nerve. 2 Cardiac sodium channels reside at specific locations as well. 25 In the present study, we observed Nav1.1, ␤ 1 , and ␤ 2 labeling along Z lines in longitudinal sections. We have also observed ␤ 1 A staining of surface membranes of cardiac myocytes when viewed in cross section. 3 It has been proposed that cardiac sodium channels may be targeted and clustered to specific locations in a manner similar to that observed for sodium channels in brain. 25 The presence of ␤-subunits in cardiac myocytes may facilitate sodium channel localization and clustering to discrete functional domains via cell-adhesive interactions. Treatment of inside-out patches of ventricular cells with cytochalasin-D induced sodium channels to enter a mode characterized by lower peak open probability with a greater persistent activity, consistent with a decrease in the rate of inactivation. 29 Sodium channels in ankyrin B -knockout mice display reduced current density and abnormal kinetics that contribute to prolonged action potential duration and abnormal QT-rate adaptation. 30 Thus, cytoskeletal interactions may be critical to sodium channel localization and gating in the heart as well as in the brain. We propose that the presence of ␤ 1 -and ␤ 2 -subunits in cardiac myocytes may facilitate channel-cytoskeletal interactions and play a key role in the regulation of the cardiac action potential.
